microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells (Q39327988)

11 September 2017

title

microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells (English)

1 reference

11 September 2017

0 references

1 reference

Imke Satzger

1

1 reference

11 September 2017

Anika Mattern

2

1 reference

11 September 2017

Uta Kuettler

3

1 reference

11 September 2017

Dirk Weinspach

4

1 reference

11 September 2017

Margarete Niebuhr

5

1 reference

11 September 2017

Alexander Kapp

6

1 reference

11 September 2017

Ralf Gutzmer

7

1 reference

11 September 2017

publication date

1 July 2012

1 reference

11 September 2017

published in

Experimental Dermatology

1 reference

11 September 2017

volume

21

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

509-514

1 reference

Distinct sets of genetic alterations in melanoma

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Driving in the melanoma landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Reproducible pattern of microRNA in normal human skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

miR-21: a small multi-faceted RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Keratinocytes enriched for epidermal stem cells differ in their response to IFN-gamma from other proliferative keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

CDC25 phosphatases in cancer cells: key players? Good targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2012.01510.X

10.1111/J.1600-0625.2012.01510.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference